Nuvalent Inc - Class A — Dividend History & Yield (NASDAQ:NUVL) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

ニュース

Nuvalent、第4四半期の損失を報告、肺がん治療薬のFDA判断を待つ

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

ニューバレント社株、52週間高値の112.89ドルを記録

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDAがNuvalentのROS1陽性NSCLC治療薬の新薬申請を受理

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock

Nuvalent CSO Pelish sells shares worth $501,752

Nuvalent (NUVL) chief development officer sells $721k in stock

What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)

3 Biotech Stocks With Major 2026 Catalysts